Methylphenidate regulates c-fos and fosB expression in multiple regions of the immature rat brain

Developmental Brain Research

Volumn 156, Issue 1, 2005, Pages 1-12

  Chase, T D ^b   Carrey, N ^a   Brown, R E ^b   Wilkinson, M ^a,b  

^a IWK HEALTH CENTRE   (Canada)

^b DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Attention deficit hyperactivity disorder; Caudate putamen; Cortex; Development; Immediate early gene; Islands of Calleja; Methylphenidate; Nucleus accumbens

Indexed keywords

METHYLPHENIDATE; PROTEIN C FOS; PSYCHOSTIMULANT AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN DEVELOPMENT; BRAIN MATURATION; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; CORPUS STRIATUM; DRUG EFFICACY; DRUG MECHANISM; FOSB GENE; FRONTAL CORTEX; GENE EXPRESSION REGULATION; GENE FUNCTION; IMMEDIATE EARLY GENE; IMMUNOREACTIVITY; LONG TERM CARE; MALE; MOLECULAR PROBE; NONHUMAN; NUCLEUS ACCUMBENS; OLFACTORY NERVOUS SYSTEM; ONCOGENE C FOS; PERINATAL PERIOD; PHARMACOGENOMICS; PRIORITY JOURNAL; PYRIFORM CORTEX; RAT; REGULATORY MECHANISM;

EID: 18044394183     PISSN: 01653806     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.devbrainres.2005.01.011     Document Type: Article

References (66)

1. S.L. Andersen Changes in the second messenger cyclic AMP during development may underlie motoric symptoms in attention deficit/hyperactivity disorder (ADHD) Behav. Brain Res. 130 2002 197 201
2. S.L. Andersen, A. Arvanitogiannis, A.M. Pliakas, C. LeBlanc, and W.A. Carlezon Jr. Altered responsiveness to cocaine in rats exposed to methylphenidate during development Nat. Neurosci. 5 2002 13 14
3. F.M. Benes Brain development, VII. Human brain growth spans decades Am. J. Psychiatry 155 1998 1489
4. C.G. Berbatis, V.B. Sunderland, and M. Bulsara Licit psychostimulant consumption in Australia, 1984-2000: international and jurisdictional comparison Med. J. Aust. 177 2002 539 543
5. J.A. Bibb, J. Chen, J.R. Taylor, P. Svenningsson, A. Nishi, G.L. Snyder, Z. Yan, Z.K. Sagawa, C.C. Ouimet, A.C. Nairn, E.J. Nestler, and P. Greengard Effects of chronic exposure to cocaine are regulated by the neuronal protein Cdk5 Nature 410 2001 376 380
6. C.L. Brandon, and H. Steiner Repeated methylphenidate treatment in adolescent rats alters gene regulation in the striatum Eur. J. Neurosci. 18 2003 1584 1592
7. C.L. Brandon, M. Marinelli, L.K. Baker, and F.J. White Enhanced reactivity and vulnerability to cocaine following methylphenidate treatment in adolescent rats Neuropsychopharmacology 25 2001 651 661
8. J.J. Canales, and A.M. Graybiel A measure of striatal function predicts motor stereotypy Nat. Neurosci. 3 2000 377 383
9. W.A. Carlezon Jr., S.D. Mague, and S.L. Andersen Enduring behavioral effects of early exposure to methylphenidate in rats Biol. Psychiatry 54 2003 1330 1337
10. N.J. Carrey, D.M. Wiggins, and R.P. Milin Pharmacological treatment of psychiatric disorders in children and adolescents: focus on guidelines for the primary care practitioner Drugs 51 1996 750 759
11. F.X. Castellanos, J.N. Giedd, P.C. Berquin, J.M. Walter, W. Sharp, T. Tran, A.C. Vaituzis, J.D. Blumenthal, J. Nelson, T.M. Bastain, A. Zijdenbos, A.C. Evans, and J.L. Rapoport Quantitative brain magnetic resonance imaging in girls with attention-deficit/hyperactivity disorder Arch. Gen. Psychiatry 58 2001 289 295
12. S.A. Castner, and P.S. Goldman-Rakic Long-lasting psychotomimetic consequences of repeated low-dose amphetamine exposure in rhesus monkeys Neuropsychopharmacology 20 1999 10 28
13. T.D. Chase, R.E. Brown, N. Carrey, and M. Wilkinson Repeated ritalin attenuates Fos-ir in the rat striatum Abstr. - Soc. Neurosci. 28 2002 808.5
14. T.D. Chase, R.E. Brown, N. Carrey, and M. Wilkinson Repeated methylphenidate attenuates c-fos expression in the striatum of prepubertal rats NeuroReport 14 2003 769 772
15. J. Chen, M.B. Kelz, B.T. Hope, Y. Nakabeppu, and E.J. Nestler Chronic Fos-related antigens: stable variants of deltaFosB induced in brain by chronic treatments J. Neurosci. 17 1997 4933 4941
16. R.P. Dilts Jr., T.E. Helton, and J.F. McGinty Selective induction of Fos and FRA immunoreactivity within the mesolimbic and mesostriatal dopamine terminal fields Synapse 13 1993 251 263
17. D.D. Dougherty, A.A. Bonab, T.J. Spencer, S.L. Rauch, B.K. Madras, and A.J. Fischman Dopamine transporter density in patients with attention deficit hyperactivity disorder Lancet 354 1999 2132 2133
18. D.J. Ennulat, S. Babb, and B.M. Cohen Persistent reduction of immediate early gene mRNA in rat forebrain following single or multiple doses of cocaine Brain Res. Mol. Brain Res. 26 1994 106 112
19. B.J. Everitt, and M.E. Wolf Psychomotor stimulant addiction: a neural systems perspective J. Neurosci. 22 2002 3312 3320
20. S.V. Faraone, and T. Wilens Does stimulant treatment lead to substance use disorders? J. Clin. Psychiatry 64 Suppl 11 2003 9 13
21. C. Freed, R. Revay, R.A. Vaughan, E. Kriek, S. Grant, G.R. Uhl, and M.J. Kuhar Dopamine transporter immunoreactivity in rat brain J. Comp. Neurol. 359 1995 340 349
22. R. Fukui, P. Svenningsson, T. Matsuishi, H. Higashi, A.C. Nairn, P. Greengard, and A. Nishi Effect of methylphenidate on dopamine/DARPP signalling in adult, but not young, mice J. Neurochem. 87 2003 1391 1401
23. R.R. Gainetdinov, W.C. Wetsel, S.R. Jones, E.D. Levin, M. Jaber, and M.G. Caron Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity Science 283 1999 397 401
24. S.J. Gatley, N.D. Volkow, A.N. Gifford, J.S. Fowler, S.L. Dewey, Y.S. Ding, and J. Logan Dopamine-transporter occupancy after intravenous doses of cocaine and methylphenidate in mice and humans Psychopharmacology (Berl) 146 1999 93 100
25. J.N. Giedd, J. Blumenthal, N.O. Jeffries, F.X. Castellanos, H. Liu, A. Zijdenbos, T. Paus, A.C. Evans, and J.L. Rapoport Brain development during childhood and adolescence: a longitudinal MRI study Nat. Neurosci. 2 1999 861 863
26. A.M. Graybiel, R. Moratalla, and H.A. Robertson Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum Proc. Natl. Acad. Sci. U. S. A. 87 1990 6912 6916
27. L. Greenhill Attention-deficit hyperactivity disorder: the stimulants Child Adolesc. Psychiatr. Clin. N. Am. 4 1995 123 168
28. C.M. Hawken, R.E. Brown, N. Carrey, and M. Wilkinson Long-term methylphenidate treatment down-regulates c-fos in the striatum of male CD-1 mice NeuroReport 15 2004 1045 1048
29. T. Herdegen, and J.D. Leah Inducible and constitutive transcription factors in the mammalian nervous system: control of gene expression by Jun, Fos and Krox, and CREB/ATF proteins Brain Res. Brain Res. Rev. 28 1998 370 490
30. B.J. Hoffman, S.R. Hansson, E. Mezey, and M. Palkovits Localization and dynamic regulation of biogenic amine transporters in the mammalian central nervous system Front. Neuroendocrinol. 19 1998 187 231
31. B.T. Hope, H.E. Nye, M.B. Kelz, D.W. Self, M.J. Iadarola, Y. Nakabeppu, R.S. Duman, and E.J. Nestler Induction of a long-lasting AP-1 complex composed of altered Fos-like proteins in brain by chronic cocaine and other chronic treatments Neuron 13 1994 1235 1244
32. P. Hughes, and M. Dragunow Induction of immediate-early genes and the control of neurotransmitter-regulated gene expression within the nervous system Pharmacol. Rev. 47 1995 133 178
33. S. Izenwasser, L.L. Werling, and B.M. Cox Comparison of the effects of cocaine and other inhibitors of dopamine uptake in rat striatum, nucleus accumbens, olfactory tubercle, and medial prefrontal cortex Brain Res. 520 1990 303 309
34. M.B. Kelz, and E.J. Nestler deltaFosB: a molecular switch underlying long-term neural plasticity Curr. Opin. Neurol. 13 2000 715 720
35. M.B. Kelz, J. Chen, W.A. Carlezon Jr., K. Whisler, L. Gilden, A.M. Beckmann, C. Steffen, Y.J. Zhang, L. Marotti, D.W. Self, T. Tkatch, G. Baranauskas, D.J. Surmeier, R.L. Neve, R.S. Duman, M.R. Picciotto, and E.J. Nestler Expression of the transcription factor deltaFosB in the brain controls sensitivity to cocaine Nature 401 1999 272 276
36. H.C. Kimko, J.T. Cross, and D.R. Abernethy Pharmacokinetics and clinical effectiveness of methylphenidate Clin. Pharmacokinet. 37 1999 457 470
37. B.E. Kosofsky, L.M. Genova, and S.E. Hyman Postnatal age defines specificity of immediate early gene induction by cocaine in developing rat brain J. Comp. Neurol. 351 1995 27 40
38. R. Kuczenski, and D.S. Segal Effects of methylphenidate on extracellular dopamine, serotonin, and norepinephrine: comparison with amphetamine J. Neurochem. 68 1997 2032 2037
39. J.S. Lin, Y. Hou, and M. Jouvet Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat Proc. Natl. Acad. Sci. U. S. A. 93 1996 14128 14133
40. M.C. MacDonald, H.A. Robertson, and M. Wilkinson Age- and dose-related NMDA induction of Fos-like immunoreactivity and c-fos mRNA in the arcuate nucleus of immature female rats Brain Res. Dev. Brain Res. 73 1993 193 198
41. B.K. Madras, G.M. Miller, and A.J. Fischman The dopamine transporter: relevance to attention deficit hyperactivity disorder (ADHD) Behav. Brain Res. 130 2002 57 63
42. J.J.A. Marota, J.B. Mandeville, R.M. Weisskoff, M.A. Moskowitz, B.R. Rosen, and B. Kosofsky Cocaine activation discriminates dopaminergic projections by temporal response: an fMRI study in rat NeuroImage 11 2000 13 23
43. E. Marshall Duke study faults overuse of stimulants for children Science 289 2000 721
44. E. Marshall Planned ritalin trial for tots heads into uncharted waters Science 290 2000 1280 1282
45. M.P. McFadyen, R.E. Brown, and N. Carrey Subchronic methylphenidate administration has no effect on locomotion, emotional behavior, or water maze learning in prepubertal mice Dev. Psychobiol. 41 2002 123 132
46. K. Minde The use of psychotropic medication in preschoolers: some recent developments Can J. Psychiatry 43 1998 571 575
47. G.H. Moll, S. Hause, E. Ruther, A. Rothenberger, and G. Huether Early methylphenidate administration to young rats causes a persistent reduction in the density of striatal dopamine transporters J. Child. Adolesc. Psychopharmacol. 11 2001 15 24
48. M. Natarajan, and M. Wilkinson Recovery of hypothalamic NMDA-induced c-fos expression following neonatal glutamate (MSG) lesions Brain Res. Dev. Brain Res. 102 1997 97 104
49. E.J. Nestler, M. Barrot, and D.W. Self DeltaFosB: a sustained molecular switch for addiction Proc. Natl. Acad. Sci. U. S. A. 98 2001 11042 11046
50. S.D. Norrholm, J.A. Bibb, E.J. Nestler, C.C. Ouimet, J.R. Taylor, and P. Greengard Cocaine-induced proliferation of dendritic spines in nucleus accumbens is dependent on the activity of cyclin-dependent kinase-5 Neuroscience 116 2003 19 22
51. M. Papa, J.A. Sergeant, and A.G. Sadile Reduced transduction mechanisms in the anterior accumbal interface of an animal model of attention-deficit hyperactivity disorder Behav. Brain Res. 94 1998 187 195
52. M. Papa, S. Sellitti, and A.G. Sadile Remodeling of neural networks in the anterior forebrain of an animal model of hyperactivity and attention deficits as monitored by molecular imaging probes Neurosci. Biobehav. Rev. 24 2000 149 156
53. G. Paxinos, and C. Watson The rat brain in stereotaxic coordinates 1986 Academic Press New York
54. M.R. Penner, M.P. McFadyen, R. Pinaud, N. Carrey, H.A. Robertson, and R.E. Brown Age-related distribution of c-fos expression in the striatum of CD-1 mice after acute methylphenidate administration Brain Res. Dev. Brain Res. 135 2002 71 77
55. L.I. Perrotti, Y. Hadeishi, P.G. Ulery, M. Barrot, L. Monteggia, R.S. Duman, and E.J. Nestler Induction of DeltaFosB in reward-related brain structures after chronic stress J. Neurosci. 24 2004 10594 10602
56. J.J. Rucklidge, and R. Tannock Psychiatric, psychosocial, and cognitive functioning of female adolescents with ADHD J. Am. Acad. Child. Adolesc. Psych. 40 2001 530 540
57. A.G. Sadile Multiple evidence of a segmental defect in the anterior forebrain of an animal model of hyperactivity and attention deficit Neurosci. Biobehav. Rev. 24 2000 161 169
58. A. Snyder-Keller, and R.W. Keller Jr. Stimulant-mediated c-fos induction in striatum as a function of age, sex, and prenatal cocaine exposure Brain Res. 794 1998 88 95
59. M.V. Solanto Dopamine dysfunction in AD/HD: integrating clinical and basic neuroscience research Behav. Brain Res. 130 2002 65 71
60. J.V. Trinh, D.L. Nehrenberg, J.P. Jacobsen, M.G. Caron, and W.C. Wetsel Differential psychostimulant-induced activation of neural circuits in dopamine transporter knockout and wild type mice Neuroscience 118 2003 297 310
61. G. Tripp, J. Ryan, and K. Peace Neuropsychological functioning in children with DSM-IV combined type attention deficit hyperactivity disorder Aust. N. Z. J. Psychiatry 36 2002 771 779
62. N.D. Volkow, G. Wang, J.S. Fowler, J. Logan, M. Gerasimov, L. Maynard, Y. Ding, S.J. Gatley, A. Gifford, and D. Franceschi Therapeutic doses of oral methylphenidate significantly increase extracellular dopamine in the human brain J. Neurosci. 21 2001 RC121
63. T.E. Wilens Impact of ADHD and its treatment on substance abuse in adults J. Clin. Psychiatry 65 Suppl 3 2004 38 45
64. T.E. Wilens, J. Biederman, and T.J. Spencer Attention deficit/hyperactivity disorder across the lifespan Annu. Rev. Med. 53 2002 113 131
65. S.M. Yatin, G.M. Miller, C. Norton, and B.K. Madras Dopamine transporter-dependent induction of C-Fos in HEK cells Synapse 45 2002 52 65
66. A.J. Zametkin, and W. Liotta The neurobiology of attention-deficit/ hyperactivity disorder J. Clin. Psychiatry 59 Suppl 7 1998 17 23